Droxinostat sensitizes human colon cancer cells to apoptotic cell death via induction of oxidative stress.

Upregulation of histone acetylation plays a critical role in the dysregulation of transcription. It alters the structure of chromatin, which leads to the onset of cancer. Histone deacetylase inhibitors may therefore be a promising way to limit cancer progression.